Gene · 5320
Papers3,288
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,288
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In-depth immunorecognition and neutralization analyses of Micrurus mipartitus and M. dumerilii venoms and toxins by a commercial antivenom. | Biochimie | 2024 | 37844754 | PubTator, text mining | PubMed |
| Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. | Genes Dis | 2024 | 37588235 | PubTator, text mining | PubMed |
| WITHDRAWN: Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation. | bioRxiv | 2024 | 37066328 | PubTator, text mining | PubMed |
| Phospholipase A2 (PLA2) injured lymphatic endothelial cells leading to progression of secondary lymphoedema. | Biotechnol Genet Eng Rev | 2024 | 36971244 | PubTator, text mining | PubMed |
| A Review of Rattlesnake Venoms. | Toxins (Basel) | 2023 | 38276526 | PubTator, text mining | PubMed |
| Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform. | Front Pharmacol | 2023 | 38273832 | PubTator, text mining | PubMed |
| Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors. | Front Pharmacol | 2023 | 38273820 | PubTator, text mining | PubMed |
| Snake Venom: A Promising Source of Neurotoxins Targeting Voltage-Gated Potassium Channels. | Toxins (Basel) | 2023 | 38251229 | PubTator, text mining | PubMed |
| Frankincense preparation promotes formation of inflammation-resolving lipid mediators by manipulating lipoxygenases in human innate immune cells. | Front Pharmacol | 2023 | 38239198 | PubTator, text mining | PubMed |
| Phospholipase A2 Group IIA Is Associated with Inflammatory Hepatocellular Adenoma. | Cancers (Basel) | 2023 | 38201587 | PubTator, text mining | PubMed |
| ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming. | Toxins (Basel) | 2023 | 38133177 | PubTator, text mining | PubMed |
| Hippo pathway in intestinal diseases: focusing on ferroptosis. | Front Cell Dev Biol | 2023 | 38130953 | PubTator, text mining | PubMed |
| Towards better antivenoms: navigating the road to new types of snakebite envenoming therapies. | J Venom Anim Toxins Incl Trop Dis | 2023 | 38116472 | PubTator, text mining | PubMed |
| Regulatory mechanisms triggered by enzyme interactions with lipid membrane surfaces. | Front Mol Biosci | 2023 | 38099197 | PubTator, text mining | PubMed |
| Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms. | Nat Commun | 2023 | 38097534 | PubTator, text mining | PubMed |
| The patatin-like phospholipase PfPNPLA2 is involved in the mitochondrial degradation of phosphatidylglycerol during Plasmodium falciparum blood stage development. | Front Cell Infect Microbiol | 2023 | 38089812 | PubTator, text mining | PubMed |
| Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease. | Front Pharmacol | 2023 | 38089059 | PubTator, text mining | PubMed |
| Editorial: The role of minerals and trace elements in chronic diseases. | Front Cell Dev Biol | 2023 | 38078008 | PubTator, text mining | PubMed |
| Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. | iScience | 2023 | 38077153 | PubTator, text mining | PubMed |
| Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies. | Molecules | 2023 | 38067472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5320/papers?page=10